Ustekinumab Dose Optimization in Crohn Disease: One Size Does Not Fit All
Inflamm Bowel Dis
.
2021 May 17;27(6):e70.
doi: 10.1093/ibd/izab019.
Authors
Rahul S Dalal
1
,
Jessica R Allegretti
1
Affiliation
1
Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
PMID:
33570151
PMCID:
PMC8128381
DOI:
10.1093/ibd/izab019
No abstract available
Publication types
Editorial
Comment
MeSH terms
Crohn Disease* / drug therapy
Humans
Remission Induction
Ustekinumab*
Substances
Ustekinumab
Grants and funding
T32 DK007533/DK/NIDDK NIH HHS/United States